<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Ovarian Cancer Trial May Help 30% More Patients
Image Overlay - Ovarian Cancer Trial May Help 30% More Patients

Ovarian Cancer Trial May Help 30% More Patients

October 16, 2019

Ovarian Cancer Trial May Help 30% More Patients

Cancer patients at the Sylvester Comprehensive Cancer Center that participated in a clinical trial for ovarian cancer have impacted the way the disease is understood. The study proved that an anti-cancer drug called veliparib, which targets the way DNA repairs itself, might help up to 30% more patients. Yourway increases access to life-saving medicine by being on the forefront of the clinical trial supply chain.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat
Come chat with us!
Hello! How can I help you?